Tencent and Bertelsmann Asia Investments have both backed the home fitness company, which will soon launch a smart display screen for its workouts.

The Biohaven spinoff has picked up $60m in its series A round as it expects to increase its headcount tenfold.

Sinopharm Capital chipped in for a series B round aimed at expanding MEDx's precision healthcare operation.

Alibaba, HIS and Line have all previously backed KKday, an online travel experience provider with more than 5 million registered users.

SoftBank has led a $68m series D round for ShipBob through its Vision Fund 2, more than doubling the logistics company’s total equity to over $130m.

Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.

Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.

GV has thrown its weight behind Monte Rosa Therapeutics, which is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

University of London-linked Monte Rosa Therapeutics is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

Creative Biosciences has collected $88m in fresh funding from a consortium of new and existing shareholders, though Kingmed Diagnostics and Tasly did not return.